EX-99.1 2 d628225dex991.htm EX-99.1 EX-99.1

EXHIBIT 99.1

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION

The unaudited pro forma condensed consolidated financial information shown below is based on historical consolidated financial statements of the Registrant. The accompanying unaudited pro forma condensed consolidated balance sheet as of June 30, 2018 presents the Registrant’s historical consolidated statement of financial position, giving effect to the disposition as if it had been completed on June 30, 2018. The accompanying unaudited pro forma condensed consolidated statements of operations for the three months ended June 30, 2018 and for the years ended March 31, 2018, 2017 and 2016 present the Registrant’s historical consolidated statements of operations, giving effect to the disposition as if it had been completed on April 1, 2015, the beginning of the earliest period presented.

The unaudited pro forma condensed consolidated financial statements include specific, factually supportable assumptions and adjustments that are directly related to the disposition. These pro forma adjustments have been made to illustrate the anticipated financial effect of the disposition on the Registrant. The adjustments are based upon available information and assumptions that the Registrant believes are reasonable as of the date of this filing. However, actual adjustments may differ materially from the information presented. Assumptions underlying the pro forma adjustments are described in the accompanying notes, which should be read in conjunction with the unaudited pro forma condensed consolidated financial information. The unaudited pro forma condensed consolidated financial statements, including notes thereto, should be read in conjunction with the historical financial statements and notes thereto of the Registrant included in the Registrant’s Quarterly Report on Form 10-Q for the three months ended June 30, 2018, and the Registrant’s Annual Report on Form 10-K for the year ended March 31, 2018.


Acxiom Corporation

Unaudited Pro Forma Condensed Consolidated Balance Sheet

As of June 30, 2018

 

(in thousands)

   Historical
Acxiom
    AMS
Adjustment

(Note A)
    Other
Pro Forma
Adjustments
   

Note
Reference

   Pro Forma
Consolidated
 

ASSETS

           

Current assets:

           

Cash and cash equivalents

   $ 95,099     $ (1,544   $ 2,044,498     (B)    $ 2,138,053  

Trade accounts receivable, net

     163,767       (110,331     —            53,436  

Refundable income taxes

     11,761       (11,789     28     (D)      —    

Other current assets

     40,167       (19,689     —            20,478  
  

 

 

   

 

 

   

 

 

      

 

 

 

Total current assets

     310,794       (143,353     2,044,526          2,190,107  

Property and equipment, net of accumulated

depreciation and amortization

     151,407       (121,288     —            30,119  

Software, net

     31,719       (20,983     —            10,736  

Goodwill

     595,795       (390,841     —            204,954  

Purchased software licenses, net

     6,670       (6,492     —            178  

Deferred income taxes

     11,488       76,443       (87,903   (D)      28  

Deferred commissions, net

     18,137       (10,696     —            7,441  

Other assets, net

     40,958       (2,246     —            38,712  
  

 

 

   

 

 

   

 

 

      

 

 

 
   $ 1,166,968     $ (619,456   $ 1,956,623        $ 2,504,135  
  

 

 

   

 

 

   

 

 

      

 

 

 

LIABILITIES AND EQUITY

           

Current liabilities:

           

Current installments of long-term debt

   $ 1,327     $ —       $ (1,327   (B)    $ —    

Trade accounts payable

     47,668       (23,713     —            23,955  

Accrued payroll and related expenses

     21,939       (11,576     —            10,363  

Other accrued expenses

     58,938       (13,498     —            45,440  

Deferred revenue

     31,621       (26,710     —            4,911  

Income taxes payable

     —         —         495,900     (D)      495,928  
         28     (D)   
  

 

 

   

 

 

   

 

 

      

 

 

 

Total current liabilities

     161,493       (75,497     494,601          580,597  
  

 

 

   

 

 

   

 

 

      

 

 

 

Long term debt

     227,435       —         (227,435   (B)      —    

Deferred income taxes

     42,258       (42,258     —            —    

Other liabilities

     13,726       (4,563     —            9,163  

Commitments and contingencies

           

Equity:

           

Common stock

     13,773       —         —            13,773  

Additional paid-in capital

     1,256,442       —         —            1,256,442  

Retained earnings

     638,043       (500,662     500,662     (B)      1,826,838  
         1,772,598     (C)   
         (583,803   (D)   

Accumulated other comprehensive income

     8,899       3,524       —            12,423  

Treasury stock, at cost

     (1,195,101     —         —            (1,195,101
  

 

 

   

 

 

   

 

 

      

 

 

 

Total equity

     722,056       (497,138     1,689,457          1,914,375  
  

 

 

   

 

 

   

 

 

      

 

 

 
   $ 1,166,968     $ (619,456   $ 1,956,623        $ 2,504,135  
  

 

 

   

 

 

   

 

 

      

 

 

 

See accompanying Notes to Pro Forma Financial Information


Acxiom Corporation

Unaudited Pro Forma Condensed Consolidated Statement of Operations

For the Three Months Ended June 30, 2018

 

(in thousands, except per share amounts)

   Historical
Acxiom
    AMS
Adjustment

(Note A)
    Other
Pro Forma
Adjustments
   

Note
Reference

   Pro Forma
Consolidated
 

Revenues

   $ 226,960     $ (164,489   $ —          $ 62,471  

Cost of revenue

     117,271       (93,617     —            23,654  
  

 

 

   

 

 

   

 

 

      

 

 

 

Gross profit

     109,689       (70,872     —            38,817  

Operating expenses:

           

Research and development

     24,536       (7,566     —            16,970  

Sales and marketing

     54,850       (21,527     —            33,323  

General and administrative

     34,718       (16,594     —            18,124  

Gains, losses, and other items, net

     1,286       (1,284     —            2  
  

 

 

   

 

 

   

 

 

      

 

 

 

Total operating expenses

     115,390       (46,971     —            68,419  
  

 

 

   

 

 

   

 

 

      

 

 

 

Income (loss) from operations

     (5,701     (23,901     —            (29,602
  

 

 

   

 

 

   

 

 

      

 

 

 

Other income (expense):

           

Interest expense

     (2,838     —         2,835     (C)      (3

Other, net

     524       (168     —            356  
  

 

 

   

 

 

   

 

 

      

 

 

 

Total other expense

     (2,314     (168     2,835          353  
  

 

 

   

 

 

   

 

 

      

 

 

 

Income (loss) from operations before income taxes

     (8,015     (24,069     2,835          (29,249

Income tax expense (benefit)

     (5,000     (6,092     11,159     (B)      67  
  

 

 

   

 

 

   

 

 

      

 

 

 

Net earnings (loss)

   $ (3,015   $ (17,977   $ (8,324      $ (29,316
  

 

 

   

 

 

   

 

 

      

 

 

 

Basic loss per share

   $ (0.04          $ (0.38

Diluted loss per share

   $ (0.04          $ (0.38

Basic shares used in the calculation of net loss per share

     76,935              76,935  

Diluted shares used in the calculation of net loss per share

     76,935              76,935  

See accompanying Notes to Pro Forma Financial Information


Acxiom Corporation

Unaudited Pro Forma Condensed Consolidated Statement of Operations

For the Fiscal Year Ended March 31, 2018

 

(in thousands, except per share amounts)

   Historical
Acxiom
    AMS
Adjustment

(Note A)
    Other
Pro Forma
Adjustments
   

Note
Reference

   Pro Forma
Consolidated
 

Revenues

   $ 917,406     $ (697,305   $ —          $ 220,101  

Cost of revenue

     466,436       (370,040     —            96,396  
  

 

 

   

 

 

   

 

 

      

 

 

 

Gross profit

     450,970       (327,265     —            123,705  

Operating expenses:

           

Research and development

     94,873       (34,168     —            60,713  

Sales and marketing

     215,599       (106,960     —            108,639  

General and administrative

     123,526       (38,372     —            85,154  

Gains, losses, and other items, net

     6,373       (3,650     —            2,723  
  

 

 

   

 

 

   

 

 

      

 

 

 

Total operating expenses

     440,371       (183,142     —            257,229  
  

 

 

   

 

 

   

 

 

      

 

 

 

Income (loss) from operations

     10,599       (144,123     —            (133,524
  

 

 

   

 

 

   

 

 

      

 

 

 

Other income (expense):

           

Interest expense

     (10,131     —         10,105     (C)      (26

Other, net

     241       287                528  
  

 

 

   

 

 

   

 

 

      

 

 

 

Total other expense

     (9,890     287       10,105          502  
  

 

 

   

 

 

   

 

 

      

 

 

 

Income (loss) from operations before income taxes

     709       (143,836     10,105          (133,022

Income tax expense (benefit)

     (22,771     25,414       2,525     (B)      118  
  

 

 

   

 

 

   

 

 

      

 

 

 

Net earnings (loss)

   $ 23,480     $ (169,250   $ (12,630      $ (133,140
  

 

 

   

 

 

   

 

 

      

 

 

 

Basic earnings (loss) per share

   $ 0.30            $ (1.69

Diluted earnings (loss) per share

   $ 0.29            $ (1.69

Basic shares used in the calculation of net earnings (loss) per share

     78,891              78,891  

Diluted shares used in the calculation of net earnings (loss) per share

     81,516              78,891  

See accompanying Notes to Pro Forma Financial Information


Acxiom Corporation

Unaudited Pro Forma Condensed Consolidated Statement of Operations

For the Fiscal Year Ended March 31, 2017

 

(in thousands, except per share amounts)

   Historical
Acxiom
    AMS
Adjustment

(Note A)
    Other
Pro Forma
Adjustments
   

Note
Reference

   Pro Forma
Consolidated
 

Revenues

   $ 880,247     $ (705,487   $ —          $ 174,760  

Cost of revenue

     477,686       (377,710     —            99,976  
  

 

 

   

 

 

   

 

 

      

 

 

 

Gross profit

     402,561       (327,777     —            74,784  

Operating expenses:

           

Research and development

     82,109       (32,742     —            49,367  

Sales and marketing

     166,676       (107,418     —            59,258  

General and administrative

     129,714       (36,815     —            92,899  

Gains, losses, and other items, net

     8,373       (3,700     —            4,673  
  

 

 

   

 

 

   

 

 

      

 

 

 

Total operating expenses

     386,872       (180,675     —            206,197  
  

 

 

   

 

 

   

 

 

      

 

 

 

Income (loss) from operations

     15,689       (147,102     —            (131,413
  

 

 

   

 

 

   

 

 

      

 

 

 

Other income (expense):

           

Interest expense

     (7,381     —         7,320     (C)      (61

Other, net

     334       378       —            712  
  

 

 

   

 

 

   

 

 

      

 

 

 

Total other expense

     (7,047     378       7,320          651  
  

 

 

   

 

 

   

 

 

      

 

 

 

Income (loss) from operations before income taxes

     8,642       (146,724     7,320          (130,762

Income tax expense (benefit)

     4,534       (47,937     43,591     (B)      188  
  

 

 

   

 

 

   

 

 

      

 

 

 

Net earnings (loss)

   $ 4,108     $ (98,787   $ (36,271      $ (130,950
  

 

 

   

 

 

   

 

 

      

 

 

 

Basic earnings (loss) per share

   $ 0.05            $ (1.69

Diluted earnings (loss) per share

   $ 0.05            $ (1.69

Basic shares used in the calculation of net earnings (loss) per share

     77,609              77,609  

Diluted shares used in the calculation of net earnings (loss) per share

     79,848              77,609  

See accompanying Notes to Pro Forma Financial Information


Acxiom Corporation

Unaudited Pro Forma Condensed Consolidated Statement of Operations

For the Fiscal Year Ended March 31, 2016

 

(in thousands, except per share amounts)

   Historical
Acxiom
    AMS
Adjustment

(Note A)
    Other
Pro Forma
Adjustments
   

Note
Reference

   Pro Forma
Consolidated
 

Revenues

   $ 850,088     $ (683,537   $ —          $ 166,551  

Cost of revenue

     488,382       (383,706     —            104,676  
  

 

 

   

 

 

   

 

 

      

 

 

 

Gross profit

     361,706       (299,831     —            61,875  

Operating expenses:

           

Research and development

     74,247       (36,108     —            38,139  

Sales and marketing

     146,176       (107,454     —            38,722  

General and administrative

     135,385       (30,141     —            105,244  

Impairment of goodwill and other assets

     6,829       (6,829     —            —    

Gains, losses, and other items, net

     12,132       (10,541     —            1,591  
  

 

 

   

 

 

   

 

 

      

 

 

 

Total operating expenses

     374,769       (191,073     —            183,696  
  

 

 

   

 

 

   

 

 

      

 

 

 

Loss from operations

     (13,063     (108,758     —            (121,821
  

 

 

   

 

 

   

 

 

      

 

 

 

Other income (expense):

           

Interest expense

     (7,669     —         7,575     (C)      (94

Other, net

     452       (900     —            (448
  

 

 

   

 

 

   

 

 

      

 

 

 

Total other expense

     (7,217     (900     7,575          (542
  

 

 

   

 

 

   

 

 

      

 

 

 

Loss from continuing operations before income taxes

     (20,280     (109,658     7,575          (122,363

Income tax expense (benefit)

     (11,632     (32,323     44,166     (B)      231  
  

 

 

   

 

 

   

 

 

      

 

 

 

Net loss from continuing operations

   $ (8,648   $ (77,355   $ (36,591      $ (122,594
  

 

 

   

 

 

   

 

 

      

 

 

 

Basic loss per share from continuing operations

   $ (0.11          $ (1.58

Diluted loss per share from continuing operations

   $ (0.11          $ (1.58

Basic shares used in the calculation of net loss per share

     77,616              77,616  

Diluted shares used in the calculation of net loss per share

     77,616              77,616  

See accompanying Notes to Pro Forma Financial Information


Acxiom Corporation

Notes to Unaudited Pro Forma Condensed Consolidated Financial Information

As of June 30, 2018 and For the Three Months Ended June 30, 2018 and For the Fiscal Years Ended March 31, 2018, 2017 and 2016

Pro Forma Adjustments to the Condensed Consolidated Balance Sheet as of June 30, 2018

 

  (A)

To eliminate the assets and liabilities to be sold in the disposition of AMS.

 

  (B)

To record net cash proceeds of $2.0 billion received from the disposition of AMS, representing cash proceeds of $2.3 billion stated sales price less closing adjustments of $26.7 million, net of $228.9 million which was used to repay outstanding indebtedness, and to eliminate AMS equity.

 

  (C)

To record the net gain on the disposition of AMS.

 

  (D)

To accrue the estimated tax impact associated with the gain on the disposition of AMS, to reflect the valuation allowance for LiveRamp’s deferred tax assets, and to reclass income tax balances.

Pro Forma Adjustments to the Condensed Consolidated Statements of Operations for the Three Months Ended June 30, 2018 and for the Fiscal Years Ended March 31, 2018, 2017 and 2016

 

  (A)

To eliminate the revenues and direct expenses in the disposition of AMS.

 

  (B)

To reflect the valuation allowance for LiveRamp’s deferred tax assets.

 

  (C)

To eliminate interest expense related to repayment of outstanding indebtedness.

Other

At April 1, 2018, the Registrant adopted ASU 2014-09, Revenue from Contracts with Customers (“Topic 606”) using the modified retrospective method through an increase in retained earnings of approximately $12.7 million. The cumulative adjustment primarily related to the capitalization of costs of obtaining customer contracts.

The impact of Topic 606 and related disclosures was reflected beginning in the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018.